Wai Yin Yeung
Duchess of Kent Children's Hospital(CN)Roche (United Kingdom)(GB)University of Hong Kong(HK)
Publications by Year
Research Areas
Neurogenetic and Muscular Disorders Research, RNA modifications and cancer, RNA Research and Splicing, Statistical Methods in Clinical Trials, Optimal Experimental Design Methods
Most-Cited Works
- → Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial(2021)209 cited
- → Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)(2023)87 cited
- → Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment(2022)61 cited
- → SUNFISH Part 2: Efficacy and Safety of Risdiplam (RG7916) in Patients with Type 2 or Non-Ambulant Type 3 Spinal Muscular Atrophy (SMA) (1260)(2020)30 cited
- → Bayesian adaptive dose‐escalation procedures for binary and continuous responses utilizing a gain function(2015)18 cited
- → Bayesian adaptive dose‐escalation designs for simultaneously estimating the optimal and maximum safe dose based on safety and efficacy(2017)16 cited